-
Taking A Gander At GenMark Diagnostics
22 May 2020 20:52 GMT
… paragraphs below. Company Overview: GenMark Diagnostics (GNMK) is a Carlsbad … , and 2C19 genotyping. GenMark Diagnostics has a market capitalization … SARS-coV-2: GenMark Diagnostics has the built-in … the Biotech Forum, Busted IPO Forum, and Insiders …
-
The Daily Biotech Pulse: European Regulatory Nod For Xeris, Amicus Falls On Data, 4 IPOs, FDA Decision For Mallinckrodt's StrataGraft Delayed
12 Feb 2021 15:46 GMT
… Ltd – ADR (NASDAQ: GTH)
GenMark Diagnostics, Inc (NASDAQ: GNMK) (moved … FDA Decision, Earnings, IPOs and Conference Presentations In … conditions, priced its downsized initial public offering of 2.66 million … Decibel Therapeutics priced its IPO of 7.062 million …
-
The Daily Biotech Pulse: FDA Panel Review For Alkermes, Axovant Gets Rare Pediatric Disease Designation, 2 IPOs
09 Oct 2020 11:26 GMT
… EUA For Second Diagnostic Panel
GenMark Diagnostics, Inc (NASDAQ: GNMK) announced … profile of the combo treatment.
IPOs
Kronos Bio, Inc., a clinical … targeting dysregulated transcription, priced its initial public offering, or IPO, of 13.16 million …
-
The Daily Biotech Pulse: Marinus Epilepsy Study Meets Goal, Novavax Reaches Vaccine Manufacturing Deal, Outset Medical's IPO
15 Sep 2020 12:22 GMT
… , IPO Flow Resumes, Oncology Conference
GenMark Molecular Test Gets CE Mark
GenMark Diagnostics, … rhinovirus, the company said.
GenMark has launched the test in …
IPOs
San Jose, California-based Outset Medical, Inc. priced its upsized initial public offering …
-
The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Bristol-Myers Squibb Earnings, Acutus Medical IPO
06 Aug 2020 12:14 GMT
… ) (reacted to second-quarter results)
GenMark Diagnostics, Inc (NASDAQ: GNMK) (announced second … (NASDAQ: NKTR) (after the close)
IPOs
Acutus Medical, Inc., an arrhythmia … diagnosed and treated, priced its initial public offering of 8.824 million shares …
-
Akoya Biosciences names former molecular diagnostics CEO as new board chair
04 Oct 2024 17:15 GMT
… the president and CEO of GenMark Diagnostics, a publicly-traded molecular diagnostics … $1.8 billion. Prior to GenMark, Mendel served as the CFO … Nasdaq in 2021 following an initial public offering, which raised $151 million. The …
-
The Daily Biotech Pulse: Genmark Pre-Announces Q1 Outperformance, Sage to Eliminate 53% of Workforce, Keros IPO
08 Apr 2020 12:20 GMT
… Results; Company Raises 2020 Guidance
GenMark Diagnostics, Inc (NASDAQ: GNMK) announced … strategic objectives.
On The Radar
IPO
Keros Therapeutics, which develops therapies … it has priced its upsized initial public offering, or IPO, of 6 million at …
-
The Daily Biotech Pulse: FDA Approves Sanofi's Meningococcal Vaccine, Pluristem Secures $54M In Funding For COVID-19 Treatment, Oric Pharma Prices IPO
24 Apr 2020 12:52 GMT
… results)
Exelixis, Inc. (NASDAQ: EXEL)
GenMark Diagnostics, Inc (NASDAQ: GNMK)
Halozyme Therapeutics … and Levaxin.
On The Radar
IPO
Oric pharma, a clinical-stage … therapeutic resistance, priced its upsized IPO of 7.5 million shares …
-
The Daily Biotech Pulse: Sangamo In Genome-Editing Therapy Deal With Biogen, FDA Nod For Biohaven, Passage Bio IPO
28 Feb 2020 12:42 GMT
… Inc. Common Stock (NASDAQ: GALT)
GenMark Diagnostics, Inc (NASDAQ: GNMK)
Genocea Biosciences … : GLYC) (before the market open)
IPO
Passage Bio, a biotech developing …
-
The Week Ahead In Biotech: Conferences, PDUFA Dates, Earnings And IPOs
28 Jul 2018 18:18 GMT
… See Also: Tricida Post-IPO Run-up Makes Goldman Wary … NASDAQ: TNDM) (after the close)
GenMark Diagnostics, Inc (NASDAQ: GNMK) (after … Therapeutics Inc (NASDAQ: PETX)
IPO
Bionano Genomics, an instrumentation company … million shares in an IPO, with the price range …
About
© 1995-2025